Provided by Tiger Trade Technology Pte. Ltd.

Fractional Shares

2,018.51
-6.6394-0.33%
Number of Gainers:405
Number of Losers:593
Number of Flat:23
PE:- -
High:2,027.39
Open:2,025.54
Low:2,015.49
Close:2,025.15
Volume:4.66B
Turnover:629.40B
Market Cap:96.61T
Float Cap:90.43T

Loading ...

Kratos Wins $35 Million National Security Hardware Production Award

Reuters
·
Aug 31

Malibu Boats Corrects Q4 Adjusted Ebitda to USD 31.39 Million After Acquisition Cost Error

Reuters
·
Aug 31

GDEV Launches Self-Tender Offer to Buy up to USD 20 Million of Shares at USD 11.03 Each

Reuters
·
Aug 31

Ascendis Enters Global Settlement, License Deal with BioMarin for Yuviwel Royalties

Reuters
·
Aug 31

Goldera Launches 2026 Exploration at Egan Gold Project, Targets Late Q3-Q4 Drilling

Reuters
·
Aug 31

PyroGenesis Wins Second Titanium Powder Order Worth Us$73,700 from US Additive Manufacturing OEM

Reuters
·
Aug 31

Helium Evolution Shares Gain DTC Eligibility for U.S. Electronic Trade Settlement

Reuters
·
Aug 31

Summit Midstream Corp - Double E Secures 550 Mmcf/D of Binding Long-Term Take-or-Pay Commitments

THOMSON REUTERS
·
Aug 31

Summit Midstream Corporation Announces Final Investment Decision on Double E Pipeline Mainline Compression Expansion

THOMSON REUTERS
·
Aug 31

Hewlett Packard Ent Price Target Raised to $82.00/Share from $80.00 by B of a Securities

Dow Jones
·
Aug 31

Seaport Therapeutics Participates in Citi Biopharma Back to School Conference Fireside Chat

Reuters
·
Aug 31

Noah Holdings Director Zhang Tianjing Files Initial Beneficial Ownership Statement

Reuters
·
Aug 31

Alamos Gold Director Claire Kennedy Exits Board After Canada Consul General Appointment

Reuters
·
Aug 31

Fuel Price Adjustment Announcement: Effective 24:00 September 11, Expected Petrol and Diesel Prices to Drop by 0.05-0.06 Yuan per Liter

Deep News
·
Aug 31

Sea President Feng Zhimin Disposes of Sea Shares Worth $495,772.2

Reuters
·
Aug 31

Eli Lilly - Taltz and Zepbound Lead to Deeper Improvements in Systemic Inflammation in Both Trials

THOMSON REUTERS
·
Aug 31

New Phase 3B Data on Lilly's Taltz (Ixekizumab) and Zepbound (Tirzepatide) Used Together Showed Improved and Durable Efficacy at One Year in Adults with Psoriatic Disease and Obesity

THOMSON REUTERS
·
Aug 31

Eli Lilly - Taltz and Zepbound Maintain or Improve Disease Activity at Week 52 Versus Taltz Alone

THOMSON REUTERS
·
Aug 31

Eli Lilly: Adverse Events in Participants Treated with Taltz and Zepbound Together were Generally Mild to Moderate

THOMSON REUTERS
·
Aug 31

Labcorp Launches Next Generation of Labcorp Global Trial Connect™ to Help Sponsors and Investigator Sites Navigate Clinical Trial Complexity

THOMSON REUTERS
·
Aug 31